NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 155 filers reported holding NEKTAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $251,000 | -93.2% | 11,616 | -80.8% | 0.02% | -83.0% |
| Q3 2018 | $3,692,000 | +305.7% | 60,558 | +224.8% | 0.14% | +309.1% |
| Q2 2018 | $910,000 | -54.6% | 18,644 | -1.1% | 0.03% | -56.6% |
| Q1 2018 | $2,003,000 | +644.6% | 18,854 | +37.2% | 0.08% | +660.0% |
| Q2 2017 | $269,000 | +15.0% | 13,742 | -28.1% | 0.01% | 0.0% |
| Q4 2016 | $234,000 | -39.8% | 19,110 | -38.5% | 0.01% | -28.6% |
| Q2 2015 | $389,000 | +18.6% | 31,093 | +47.0% | 0.01% | +27.3% |
| Q4 2014 | $328,000 | +87.4% | 21,149 | +45.9% | 0.01% | +120.0% |
| Q3 2014 | $175,000 | +33.6% | 14,496 | +41.9% | 0.01% | +25.0% |
| Q2 2014 | $131,000 | -41.3% | 10,215 | -44.4% | 0.00% | -33.3% |
| Q1 2014 | $223,000 | -13.2% | 18,383 | -19.0% | 0.01% | -25.0% |
| Q4 2013 | $257,000 | – | 22,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |